Golden jubilee of the DNA double helix

Trends in Biotechnology

Volumn 21, Issue 4, 2003, Pages 139-140

  Demidov, Vadim V ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID BASE;

ACHIEVEMENT; BIOMEDICINE; BIOTECHNOLOGY; COMMERCIAL PHENOMENA; DNA HELIX; EDITORIAL; GENE THERAPY; GENETIC ANALYSIS; HYBRIDIZATION; INFORMATION SCIENCE; NUCLEIC ACID PROBE; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0037385384     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(03)00031-3     Document Type: Editorial

References (37)

1. Watson J.D., Crick F.H.C. Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature. 171:1953;737-738.
2. Crick F.H., et al. Is DNA really a double helix? J. Mol. Biol. 129:1979;449-457.
3. Frank-Kamenetskii M.D. Unraveling DNA: The Most Important Molecule of Life. 1997;Perseus Books.
4. Alcamo I.E. DNA Technology: The Awesome Skill. 2000;Academic Press.
5. Trifonov E.N. Earliest pages of bioinformatics. Bioinformatics. 16:2000;5-9.
6. Dangler C.A. Nucleic Acid Analysis. Principles and Bioapplications. 1996;Wiley-Liss.
7. Sambrook J., et al. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbour Laboratory Press.
8. Uhlmann E. Recent advances in the medicinal chemistry of antisense oligonucleotides. Curr. Opin. Drug Discov. Dev. 3:2000;203-213.
9. Winters T.A. Gene targeted agents: new opportunities for rational drug development. Curr. Opin. Mol. Ther. 2:2000;670-681.
10. Anderson W.F. Gene therapy scores against cancer. Nat. Med. 6:2000;862-863.
11. Seeman N.C., Belcher A.M. Emulating biology: building nanostructures from the bottom up. Proc. Natl. Acad. Sci. U.S.A. 99:2002;6451-6455.
12. Niemeyer C.M. Nanotechnology. Tools for the biomolecular engineer. Science. 297:2002;62-63.
13. Tsunoda Y., Kato Y. Recent progress and problems in animal cloning. Differentiation. 69:2002;158-161.
14. Illmensee K. Biotechnology in reproductive medicine. Differentiation. 69:2002;167-173.
15. Caldwell M. The dream vaccine. Discover. (September issue):1997;84-88.
16. Taubes G. Salvation in a snippet of DNA? Science. 278:1997;1711-1714.
17. Benenson Y., et al. Programmable and autonomous computing machine made of biomolecules. Nature. 414:2001;430-434.
18. Normile D. Molecular computing. DNA-based computer takes aim at genes. Science. 295:2002;951.
19. Uhlmann E., Peyman A. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 90:1990;543-584.
20. Nielsen P.E., et al. Sequence selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science. 254:1991;1497-1500.
21. Ray A., Nordén B. Peptide nucleic acid (PNA): its medical and biotechnological applications and promise for the future. FASEB J. 14:2000;1041-1060.
22. Demidov V.V. New kids on the block: emerging PNA-based DNA diagnostics. Expert Rev. Mol. Diagn. 2:2002;89-91.
23. Demidov V.V. PNA comes of age: from infancy to maturity. Drug Discov. Today. 7:2002;153-155.
24. Ganesh K.N., Nielsen P.E. Peptide nucleic acids. Analogs and derivatives. Curr. Org. Chem. 4:2000;916-928.
25. Braasch D.A., Corey D.R. Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry. 41:2002;4503-4510.
26. Horlacher J., et al. Recognition by viral and cellular DNA polymerases of nucleosides bearing bases with nonstandard hydrogen bonding patterns. Proc. Natl. Acad. Sci. U.S.A. 92:1995;6329-6333.
27. Morales J.C., Kool E.T. Efficient replication between non-hydrogen-bonded nucleoside shape analogs. Nat. Struct. Biol. 5:1998;950-954.
28. Zimmermann N., et al. A novel silver(I)-mediated DNA base pair. J. Am. Chem. Soc. 124:2002;13684-13685.
29. Kutyavin I.V., et al. Oligonucleotides containing 2-aminoadenine and 2-thiothymine act as selectively binding complementary agents. Biochemistry. 35:1996;11170-11176.
30. Lohse J., et al. Double duplex invasion by peptide nucleic acid: a general principle for sequence-specific targeting of double-stranded DNA. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11804-11808.
31. Senior K. Pseudocomplementary strategy strengthens PNA therapeutic potential. Drug Discov. Today. 5:2000;538-540.
32. Demidov V.V., et al. Kinetics and mechanism of the DNA double helix invasion by pseudocomplementary peptide nucleic acids. Proc. Natl. Acad. Sci. U.S.A. 99:2002;5953-5958.
33. Sisido M., Hohsaka T. Introduction of specialty functions by the position-specific incorporation of nonnatural amino acids into proteins through four-base codon/anticodon pairs. Appl. Microbiol. Biotechnol. 57:2001;274-281.
34. Wang L., Schultz P.G. Expanding the genetic code. Chem. Commun. 1:2002;1-11.
35. Palevitz B.A. Awash in DNA news. The Scientist. 16:2002;8.
36. Watson J.D. The Double Helix (A Norton Critical Edition). 1980;W.W. Norton and Company.
37. Maddox B. Rosalind Franklin: The Dark Lady of DNA. 2002;Harper Collins Publishers.